The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Abstract Details
The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022
ESMO Open. 2023 May 30;8(3):101567. doi: 10.1016/j.esmoop.2023.101567.Online ahead of print.
11Department of Oncology, OncoHealth Institute, Fundación Jiménez Díaz University Hospital, Madrid, Spain; Department of Medical Oncology, The Christie NHS Foundation, Manchester; Division of Cancer Sciences, University of Manchester, Manchester, UK.
12Institut du cancer Paris CARPEM, APHP, Georges Pompidou Hospital, Université Paris Cité, Paris, France.
13Icahn School of Medicine at Mount Sinai, Mount Sinai Liver Cancer Program, New York, USA; Institut d'Investigacions Biomèdiques August Pi i Sunyer Hospital Clínic, Universitat de Barcelona, Barcelona; Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain.
14University of Leipzig Medical Center, Comprehensive Cancer Center Central Germany, Leipzig, Germany.
15Vall d'Hebron Hospital Campus, Barcelona, Spain; Institute of Oncology, IOB-Quiron, UVic-UCC, Barcelona, Spain.
16American University of Beirut, Beirut, Lebanon.
17Aichi Cancer Center Hospital, Nagoya, Japan.
18Masaryk Memorial Cancer Institute, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
19Instituto Alexander Fleming, Buenos Aires, Argentina.
20Memorial Sloan Kettering Cancer Center, New York; Weill Cornell College of Medicine, New York, USA.
21Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden; Tampere University Hospital, University of Tampere, Tampere, Finland.
22Henry Ford Cancer Institute, Departments of Oncology and Pharmacology, Wayne State University, Detroit, USA.
23Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
24Instituto Nacional de Cancerologia, Mexico, Mexico.
25Clinica Universidad de Navarra and CIBEREHD, Pamplona, Spain.
26Ulm University Hospital, Ulm, Germany.
27Vall d'Hebron Hospital Campus and Institute of Oncology, IOB-Quiron, UVic-UCC, Barcelona, Spain.
28Hammersmith Hospital, Imperial College London, London, UK.
Abstract
This article summarises expert discussion on the management of patients with hepatocellular carcinoma (HCC), which took place during the 24th World Gastrointestinal Cancer Congress (WGICC) in Barcelona, July 2022. A multidisciplinary approach is mandatory to ensure an optimal diagnosis and staging of HCC, planning of curative and therapeutic options, including surgical, embolisation, ablative strategies, or systemic therapy. Furthermore, in many patients with HCC, underlying liver cirrhosis represents a challenge and influences the therapeutic options.